Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye : A Randomized Double-blind Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06860659
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:46.516972+00:00
Published At
2025-03-06T00:00:00+00:00
Record Updated At
2025-03-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Dry Eye Disease (DED)", "Tear Break-Up Time", "Tear Disorder", "Tear Film Insufficiency", "Tear Film Hyperosmolarity", "Dry Eye", "Hyaluronate", "Hyaluronic Acid", "Corneal Staining", "Quality of Life"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-06"
protocolSection.identificationModule.nctId
"NCT06860659"
protocolSection.identificationModule.officialTitle
"Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye : A Randomized Double-blind Controlled Trial"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Dry Eye Disease (DED) (protocolSection.conditionsModule.conditions)
  • Tear Break-Up Time (protocolSection.conditionsModule.conditions)
  • Tear Disorder (protocolSection.conditionsModule.conditions)
  • Tear Film Insufficiency (protocolSection.conditionsModule.conditions)
  • Tear Film Hyperosmolarity (protocolSection.conditionsModule.conditions)
  • Dry Eye (protocolSection.conditionsModule.conditions)
  • Hyaluronate (protocolSection.conditionsModule.conditions)
  • Hyaluronic Acid (protocolSection.conditionsModule.conditions)
  • Corneal Staining (protocolSection.conditionsModule.conditions)
  • Quality of Life (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.